BOSTON SCIENTIFIC CORPORATION Restructuring Reserve, Period Expense (Deprecated 2012-01-31)
BOSTON SCIENTIFIC CORPORATION (BSX) reported Restructuring Reserve, Period Expense (Deprecated 2012-01-31) of $44.00 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-07.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringReservePeriodExpense · last filed 2012-08-07
- BOSTON SCIENTIFIC CORPORATION restructuring reserve, period expense (deprecated 2012-01-31) for the quarter ending 2012-06-30 was $31.00M, a 72.22% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION restructuring reserve, period expense (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $13.00M, a 65.79% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION restructuring reserve, period expense (deprecated 2012-01-31) for the quarter ending 2011-12-31 was $15.00M.
- BOSTON SCIENTIFIC CORPORATION restructuring reserve, period expense (deprecated 2012-01-31) for the quarter ending 2011-09-30 was $21.00M.
- BOSTON SCIENTIFIC CORPORATION restructuring reserve, period expense (deprecated 2012-01-31) for fiscal 2009 was $22.00M, a 67.65% decline from fiscal 2008.
- BOSTON SCIENTIFIC CORPORATION restructuring reserve, period expense (deprecated 2012-01-31) for fiscal 2008 was $68.00M, a 59.52% decline from fiscal 2007.
- BOSTON SCIENTIFIC CORPORATION restructuring reserve, period expense (deprecated 2012-01-31) for fiscal 2007 was $168.00M.
| Period end | Restructuring Reserve, Period Expense (Deprecated 2012-01-31) 3 month | Restructuring Reserve, Period Expense (Deprecated 2012-01-31) 6 month | Restructuring Reserve, Period Expense (Deprecated 2012-01-31) 9 month | Restructuring Reserve, Period Expense (Deprecated 2012-01-31) 12 month | Restructuring Reserve, Period Expense (Deprecated 2012-01-31) 12 month as first filed |
|---|---|---|---|---|---|
| 2012-06-30 | $31.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $44.00M 10-Q · filed 2012-08-07 | $59.00M derived: sum of 3 quarters · filed 2012-08-07 | $80.00M derived: sum of 4 quarters · filed 2012-08-07 | |
| 2012-03-31 | $13.00M 10-Q · filed 2012-05-03 | $28.00M derived: sum of 2 quarters · filed 2012-08-07 | $49.00M derived: sum of 3 quarters · filed 2012-08-07 | $67.00M derived: sum of 4 quarters · filed 2012-08-07 | |
| 2011-12-31 | $15.00M derived: 10-Q 12 month − 10-Q 9 month · filed 2012-08-07 | $36.00M derived: sum of 2 quarters · filed 2012-08-07 | $54.00M derived: sum of 3 quarters · filed 2012-08-07 | $92.00M 10-Q · filed 2012-08-07 | |
| 2011-09-30 | $21.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $39.00M derived: sum of 2 quarters · filed 2011-11-08 | $77.00M 10-Q · filed 2011-11-08 | ||
| 2011-06-30 | $18.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05 | $56.00M 10-Q · filed 2011-08-05 | |||
| 2011-03-31 | $38.00M 10-Q · filed 2011-05-05 | ||||
| 2010-12-31 | $98.00M 10-Q · filed 2012-08-07 | $107.00M 10-K · filed 2011-02-17 | |||
| 2009-12-31 | $22.00M 10-K · filed 2012-02-17 | $51.00M 10-K · filed 2011-02-17 | |||
| 2008-12-31 | $68.00M 10-K · filed 2011-02-17 | ||||
| 2007-12-31 | $168.00M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |